Sushil Pokhrel

Mr. Sushil Pokhrel

Systems Design (Machine Learning), University of Waterloo, Waterloo, Ontario, Canada
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2021 in Molecules
Verified
Journal Article
Open access
PDF file
TBThamer Ahmed Bouback
Thamer Ahmed Bouback
Sushil PokhrelSushil Pokhrel
Sushil Pokhrel
AAAbdulaziz Albeshri
Abdulaziz Albeshri
AAAmal Mohammed Aljohani
Amal Mohammed Aljohani
Abdus SamadAbdus Samad
Abdus Samad
Jesus Simal-GandaraJesus Simal-Gandara
Jesus Simal-Gandara
Middle East respiratory syndrome coronavirus (MERS-CoV) is a highly infectious zoonotic virus first reported into the human population in September 2012 on the Arabian Peninsula. The virus causes severe and often lethal respiratory illness in humans with an unusually high fatality rate. The N-terminal domain (NTD) of receptor-binding S1 subunit of coronavirus spike (S) proteins can recognize a variety of host protein and mediates entry into human host cells. Blocking the entry by targeting the S1-NTD of the virus can facilitate the development of effective antiviral drug candidates against the pathogen. Therefore, the study has been designed to identify effective antiviral drug candidates against the MERS-CoV by targeting S1-NTD. Initially, a structure-based pharmacophore model (SBPM) to the active site (AS) cavity of the S1-NTD has been generated, followed by pharmacophore-based virtual screening of 11,295 natural compounds. Hits generated through the pharmacophore-based virtual screening have re-ranked by molecular docking and further evaluated through the ADMET properties. The compounds with the best ADME and toxicity properties have been retrieved, and a quantum mechanical (QM) based density-functional theory (DFT) has been performed to optimize the geometry of the selected compounds. Three optimized natural compounds, namely Taiwanhomoflavone B (Amb23604132), 2,3-Dihydrohinokiflavone (Amb23604659), and Sophoricoside (Amb1153724), have exhibited substantial docking energy >−9.00 kcal/mol, where analysis of frontier molecular orbital (FMO) theory found the low chemical reactivity correspondence to the bioactivity of the compounds. Molecular dynamics (MD) simulation confirmed the stability of the selected natural compound to the binding site of the protein. Additionally, molecular mechanics generalized born surface area (MM/GBSA) predicted the good value of binding free energies (ΔG bind) of the compounds to the desired protein. Convincingly, all the results support the potentiality of the selected compounds as natural antiviral candidates against the MERS-CoV S1-NTD.

17 July 2024 in Frontiers in Chemistry
Verified
Journal Article
Open access
PDF file
ETEnamul Kabir Talukder
Enamul Kabir Talukder
AKAktaruzzaman
Aktaruzzaman
NSNoimul Hasan Siddiquee
Noimul Hasan Siddiquee
SISabrina Islam
Sabrina Islam
TWTanveer A. Wani
Tanveer A. Wani
Foysal AhammadFoysal Ahammad
Foysal Ahammad
Background: Rearranged during transfection (RET), an oncogenic protein, is associated with various cancers, including non-small-cell lung cancer (NSCLC), papillary thyroid cancer (PTC), pancreatic cancer, medullary thyroid cancer (MTC), breast cancer, and colorectal cancer. Dysregulation of RET contributes to cancer development, highlighting the importance of identifying lead compounds targeting this protein due to its pivotal role in cancer progression. Therefore, this study aims to discover effective lead compounds targeting RET across different cancer types and evaluate their potential to inhibit cancer progression.Methods: This study used a range of computational techniques, including Phase database creation, high-throughput virtual screening (HTVS), molecular docking, molecular mechanics with generalized Born surface area (MM-GBSA) solvation, assessment of pharmacokinetic (PK) properties, and molecular dynamics (MD) simulations, to identify potential lead compounds targeting RET.Results: Initially, a high-throughput virtual screening of the ZINC database identified 2,550 compounds from a pool of 170,269. Subsequent molecular docking studies revealed 10 compounds with promising negative binding scores ranging from −8.458 to −7.791 kcal/mol. MM-GBSA analysis further confirmed the potential of four compounds to exhibit negative binding scores. MD simulations demonstrated the stability of CID 95842900, CID 137030374, CID 124958150, and CID 110126793 with the target receptors.Conclusion: These findings suggest that these selected four compounds have the potential to inhibit phosphorylated RET (pRET) tyrosine kinase activity and may represent promising candidates for the treatment of various cancers.

20 April 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
AAAmer H. Asseri
Amer H. Asseri
Md Jahidul AlamMd Jahidul Alam
Md Jahidul Alam
Faisal A AlzahraniFaisal A Alzahrani
Faisal A Alzahrani
AKAhmed Khames
Ahmed Khames
MPMohammad Turhan Pathan
Mohammad Turhan Pathan
STShing Cheng Tan
Shing Cheng Tan
Merkel cell carcinoma (MCC) is a rare form of aggressive skin cancer mainly caused by Merkel cell polyomavirus (MCPyV). Most MCC tumors express MCPyV large T (LT) antigens and play an important role in the growth-promoting activities of oncoproteins. Truncated LT promotes tumorigenicity as well as host cell proliferation by activating the viral replication machinery, and inhibition of this protein in humans drastically lowers cellular growth linked to the corresponding cancer. Our study was designed with the aim of identifying small molecular-like natural antiviral candidates that are able to inhibit the proliferation of malignant tumors, especially those that are aggressive, by blocking the activity of viral LT protein. To identify potential compounds against the target protein, a computational drug design including molecular docking, ADME (absorption, distribution, metabolism, and excretion), toxicity, molecular dynamics (MD) simulation, and molecular mechanics generalized Born surface area (MM-GBSA) approaches were applied in this study. Initially, a total of 2190 phytochemicals isolated from 104 medicinal plants were screened using the molecular docking simulation method, resulting in the identification of the top five compounds having the highest binding energy, ranging between −6.5 and −7.6 kcal/mol. The effectiveness and safety of the selected compounds were evaluated based on ADME and toxicity features. A 250 ns MD simulation confirmed the stability of the selected compounds bind to the active site (AS) of the target protein. Additionally, MM-GBSA analysis was used to determine the high values of binding free energy (ΔG bind) of the compounds binding to the target protein. The five compounds identified by computational approaches, Paulownin (CID: 3084131), Actaealactone (CID: 11537736), Epigallocatechin 3-O-cinnamate (CID: 21629801), Cirsilineol (CID: 162464), and Lycoricidine (CID: 73065), can be used in therapy as lead compounds to combat MCPyV-related cancer. However, further wet laboratory investigations are required to evaluate the activity of the drugs against the virus.

11 May 2022 in Cureus
Verified
Journal Article
Open access
MDMaurice H. Dick
Maurice H. Dick
AAArowa Abdelgadir
Arowa Abdelgadir
VKVaishnavi Vijaya Kulkarni
Vaishnavi Vijaya Kulkarni
HAHamna Akram
Hamna Akram
ACAbanti Chatterjee
Abanti Chatterjee
SKSafeera Khan
Safeera Khan
Sickle cell disease (SCD) is a group of inherited red blood cell disorders affecting millions worldwide. The median life expectancy of someone with SCD remains significantly low despite improvements in standards of care and the implementation of hydroxyurea therapy. Notably, a 20-year interval existed (after the implementation of hydroxyurea therapy) prior to the approval of other sickle cell medications, namely, l-glutamine, voxelotor, and crizanlizumab. In this systematic review, these new medications' impact on the occurrences of vaso-occlusive crisis (VOC) events were analyzed and the adverse events of each were noted. Further, a secondary analysis was conducted to determine the effect of combination therapies, whether synergistic, antagonistic, or additive. The systematic review was conducted following the PRISMA 2020 guidelines. The effect-based and dose-effect-based approaches were utilized to determine the combined drugs combination index based on the recommended dosage to achieve an efficacy of 50%. L-glutamine and crizanlizumab were effective in reducing the frequency of VOC (p= 0.0216 and p = 0.02). Voxelotor effect on the reduction of VOC occurrences was not significant, however, its effect on increasing hemoglobin levels was significant (p= <0.001). In all three therapies, pain was the most common adverse event reported by participants. The analysis of combination therapies revealed that voxelotor plus l-glutamine was synergistic, voxelotor plus crizanlizumab was antagonistic, and l-glutamine plus crizanlizumab was additive. Thus, voxelotor plus l-glutamine combination therapy may be more beneficial to sickle cell disease patients. As such, robust combination drug studies for approved therapies used in SCD should be initiated with a specific focus on voxelotor plus l-glutamine. Additionally, the development of medications that lessen the pain burden in sickle cell disease patients should also be prioritized.

11 September 2024 in Information
Verified
Journal Article
Open access
PDF file
ASAmandeep Singh
Amandeep Singh
YMYovela Murzello
Yovela Murzello
Sushil PokhrelSushil Pokhrel
Sushil Pokhrel
SSSiby Samuel
Siby Samuel
Autonomous vehicles (AVs) face critical decisions in pedestrian interactions, necessitating ethical considerations such as minimizing harm and prioritizing human life. This study investigates machine learning models to predict human decision making in simulated driving scenarios under varying pedestrian configurations and time constraints. Data were collected from 204 participants across 12 unique simulated driving scenarios, categorized into young (24.7 ± 3.5 years, 38 males, 64 females) and older (71.0 ± 5.7 years, 59 males, 43 females) age groups. Participants’ binary decisions to maintain or change lanes were recorded. Traditional logistic regression models exhibited high precision but consistently low recall, struggling to identify true positive instances requiring intervention. In contrast, the AdaBoost algorithm demonstrated superior accuracy and discriminatory power. Confusion matrix analysis revealed AdaBoost’s ability to achieve high true positive rates (up to 96%) while effectively managing false positives and negatives, even under 1 s time constraints. Learning curve analysis confirmed robust learning without overfitting. AdaBoost consistently outperformed logistic regression, with AUC-ROC values ranging from 0.82 to 0.96. It exhibited strong generalization, with validation accuracy approaching 0.8, underscoring its potential for reliable real-world AV deployment. By consistently identifying critical instances while minimizing errors, AdaBoost can prioritize human safety and align with ethical frameworks essential for responsible AV adoption.

22 January 2025 in Decision Analytics Journal
Verified
Journal Article
Open access
ASAmandeep Singh
Amandeep Singh
YMYovela Murzello
Yovela Murzello
Sushil PokhrelSushil Pokhrel
Sushil Pokhrel
SSSiby Samuel
Siby Samuel